Chul Kim

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Oxide Nanoparticles

Tyrosine Kinase

Neuroendocrine Tumors

Top Venues

JCO precision oncology

Journal for immunotherapy of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of medical case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, Asaf Maoz, Amin H Nassar, Elio Adib, Khalil Choucair, Joanne Xiu, Yasmine Baca, Biagio Ricciuti, Joao M Victor Alessi, Mark M Awad, Chul Kim, Julia Judd, Luis E Raez, Gilberto de Lima Lopes, Jorge J Nieva, Hossein Borghaei, Naoko Takebe, Patrick C Ma, Balazs Halmos, David J Kwiatkowski, Stephen V Liu, Hirva Mamdani
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11 -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, Asaf Maoz, Amin H Nassar, Elio Adib, Khalil Choucair, Joanne Xiu, Yasmine Baca, Biagio Ricciuti, Joao M Victor Alessi, Mark M Awad, Chul Kim, Julia Judd, Luis E Raez, Gilberto de Lima Lopes, Jorge J Nieva, Hossein Borghaei, Naoko Takebe, Patrick C Ma, Balazs Halmos, David J Kwiatkowski, Stephen V Liu, Hirva Mamdani
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11 -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, Asaf Maoz, Amin H Nassar, Elio Adib, Khalil Choucair, Joanne Xiu, Yasmine Baca, Biagio Ricciuti, Joao M Victor Alessi, Mark M Awad, Chul Kim, Julia Judd, Luis E Raez, Gilberto de Lima Lopes, Jorge J Nieva, Hossein Borghaei, Naoko Takebe, Patrick C Ma, Balazs Halmos, David J Kwiatkowski, Stephen V Liu, Hirva Mamdani
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11 -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, Asaf Maoz, Amin H Nassar, Elio Adib, Khalil Choucair, Joanne Xiu, Yasmine Baca, Biagio Ricciuti, Joao M Victor Alessi, Mark M Awad, Chul Kim, Julia Judd, Luis E Raez, Gilberto de Lima Lopes, Jorge J Nieva, Hossein Borghaei, Naoko Takebe, Patrick C Ma, Balazs Halmos, David J Kwiatkowski, Stephen V Liu, Hirva Mamdani
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11 -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Amin H Nassar, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingjia Li, Arjun Mittra, Dwight H Owen, Robert A Baiocchi, Michael Lorentsen, Christopher Dittus, Nazli Dizman, Adewunmi Falohun, Noha Abdel-Wahab, Adi Diab, Anand Bankapur, Alexandra Reed, Chul Kim, Aakriti Arora, Neil J Shah, Edward El-Am, Elie Kozaily, Wassim Abdallah, Ahmad Al-Hader, Batool Abu Ghazal, Anwaar Saeed, Claire Drolen, Melissa G Lechner, Alexandra Drakaki, Javier Baena, Caroline A Nebhan, Tarek Haykal, Michael A Morse, Alessio Cortellini, David James Pinato, Alessia Dalla Pria, Evan Thomas Hall, Veli Bakalov, Nathan Bahary, Aarthi Rajkumar, Ankit Mangla, Vishal S Shah, Parminder Singh, Frank Aboubakar Nana, Nerea Lopetegui Lia, Danai Dima, Ryan W Dobbs, Pauline Funchain, Rabia Saleem, Rachel G Woodford, Georgina V Long, Alexander M Menzies, Carlo Genova, Giulia Barletta, Sonam Puri, Vaia Florou, Dame Idossa, Maristella Saponara, Paola Queirolo, Giuseppe Lamberti, Alfredo Addeo, Melissa Bersanelli, Dory Freeman, Wanling Xie, Erin G Reid, Elizabeth Yu Chiao, Elad Sharon, Douglas B Johnson, Ramya Ramaswami, Mark Bower, Brinda Emu, Thomas U Marron, Toni K Choueiri, Lindsey R Baden, Kathryn Lurain, Guru P Sonpavde, Abdul Rafeh Naqash
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Amin H Nassar, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingjia Li, Arjun Mittra, Dwight H Owen, Robert A Baiocchi, Michael Lorentsen, Christopher Dittus, Nazli Dizman, Adewunmi Falohun, Noha Abdel-Wahab, Adi Diab, Anand Bankapur, Alexandra Reed, Chul Kim, Aakriti Arora, Neil J Shah, Edward El-Am, Elie Kozaily, Wassim Abdallah, Ahmad Al-Hader, Batool Abu Ghazal, Anwaar Saeed, Claire Drolen, Melissa G Lechner, Alexandra Drakaki, Javier Baena, Caroline A Nebhan, Tarek Haykal, Michael A Morse, Alessio Cortellini, David James Pinato, Alessia Dalla Pria, Evan Thomas Hall, Veli Bakalov, Nathan Bahary, Aarthi Rajkumar, Ankit Mangla, Vishal S Shah, Parminder Singh, Frank Aboubakar Nana, Nerea Lopetegui Lia, Danai Dima, Ryan W Dobbs, Pauline Funchain, Rabia Saleem, Rachel G Woodford, Georgina V Long, Alexander M Menzies, Carlo Genova, Giulia Barletta, Sonam Puri, Vaia Florou, Dame Idossa, Maristella Saponara, Paola Queirolo, Giuseppe Lamberti, Alfredo Addeo, Melissa Bersanelli, Dory Freeman, Wanling Xie, Erin G Reid, Elizabeth Yu Chiao, Elad Sharon, Douglas B Johnson, Ramya Ramaswami, Mark Bower, Brinda Emu, Thomas U Marron, Toni K Choueiri, Lindsey R Baden, Kathryn Lurain, Guru P Sonpavde, Abdul Rafeh Naqash
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Paul Sackstein, Jacob Zaemes, Chul Kim
Pembrolizumab-induced cytokine release syndrome in a patient with metastatic lung adenocarcinoma: a case report. Journal for immunotherapy of cancer 9 (7) (2022)
Elizabeth Dudnik, Samuel Kareff, Mor Moskovitz, Chul Kim, Stephen V Liu, Anastasiya Lobachov, Teodor Gottfried, Damien Urban, Alona Zer, Ofer Rotem, Amir Onn, Mira Wollner, Jair Bar, null null
Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung. Journal for immunotherapy of cancer 9 (2) (2022)
Muneeb Rehman, Chul Kim, Joshua E Reuss, Lesli A Kiedrowski, Ravin J Garg, Stephen V Liu
Divergent RET - and BRAF -Mediated Resistance to Osimertinib in EGFR -Mutant NSCLC: A Case Report. JCO precision oncology 5 (2022)
Vincent Yeung, Paul Sackstein, Nazaneen N Grant, Rebecca Krochmal, Nishant Gandhi, Charu Aggarwal, Balazs Halmos, Joshua E Reuss, Stephen V Liu, Chul Kim
Use of Erdafitinib in FGFR3 -Mutated Recurrent Respiratory Papillomatosis. JCO precision oncology 6 (2022)
Chul Kim, Stephen V Liu, Deepa S Subramaniam, Tisdrey Torres, Massimo Loda, Giuseppe Esposito, Giuseppe Giaccone
Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung. Journal for immunotherapy of cancer 8 (2) (2021)
Julia Judd, Nagla Abdel Karim, Hina Khan, Abdul Rafeh Naqash, Yasmine Baca, Joanne Xiu, Ari M VanderWalde, Hirva Mamdani, Luis E Raez, Misako Nagasaka, Sachin Gopalkrishna Pai, Mark A Socinski, Jorge J Nieva, Chul Kim, Antoinette J Wozniak, Chukwuemeka Ikpeazu, Gilberto de Lima Lopes, Alexander I Spira, Wolfgang Michael Korn, Edward S Kim, Stephen V Liu, Hossein Borghaei
Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer. Molecular cancer therapeutics 20 (12) (2021)
Samuel A Kareff, Jonathan W Lischalk, Rebecca Krochmal, Chul Kim
Abscopal effect in pulmonary carcinoid tumor following ablative stereotactic body radiation therapy: a case report. Journal of medical case reports 14 (1) (2020)
Adriana Estrada-Bernal, Anh T Le, Andrea E Doak, Vijaya G Tirunagaru, Shevan Silva, Matthew R Bull, Jeff B Smaill, Adam V Patterson, Chul Kim, Stephen V Liu, Robert C Doebele
Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (5) (2020)
Neil J Shah, Ghassan Al-Shbool, Matthew Blackburn, Michael Cook, Anas Belouali, Stephen V Liu, Subha Madhavan, Aiwu Ruth He, Michael B Atkins, Geoffrey T Gibney, Chul Kim
Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection. Journal for immunotherapy of cancer 7 (1) (2019)